GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuformix PLC (LSE:NFX) » Definitions » Tax Expense

Nuformix (LSE:NFX) Tax Expense : £-0.00 Mil (TTM As of Sep. 2022)


View and export this data going back to 2015. Start your Free Trial

What is Nuformix Tax Expense?

Nuformix's tax expense for the months ended in Sep. 2022 was £-0.00 Mil. Its tax expense for the trailing twelve months (TTM) ended in Sep. 2022 was £-0.00 Mil.


Nuformix Tax Expense Historical Data

The historical data trend for Nuformix's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuformix Tax Expense Chart

Nuformix Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Tax Expense
Get a 7-Day Free Trial -0.13 -0.18 -0.17 -0.12 -0.16

Nuformix Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.12 - -0.16 - -

Nuformix Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Sep. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nuformix  (LSE:NFX) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Nuformix Tax Expense Related Terms

Thank you for viewing the detailed overview of Nuformix's Tax Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Nuformix (LSE:NFX) Business Description

Traded in Other Exchanges
Address
60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Nuformix PLC is a pharmaceutical development company. It operates in the field of pharmaceutical development targeting unmet medical needs in fibrosis and oncology via drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.